About
Linagliptin/Dapagliflozin is a fixed-dose combination medication for the treatment of type 2 diabetes mellitus, combining two distinct and complementary mechanisms of action. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of active incretin hormones, such as GLP-1 and GIP. These hormones enhance glucose-dependent insulin secretion from pancreatic beta cells and suppress glucagon secretion from alpha cells, thereby improving postprandial and fasting glucose levels.
Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces renal glucose reabsorption in the kidneys, leading to increased urinary glucose excretion. This mechanism lowers blood glucose independently of insulin. The combination provides comprehensive glycemic control, addressing both insulin secretion/sensitivity and renal glucose handling. Furthermore, this combination offers additional benefits such as modest weight reduction, blood pressure lowering, and significant cardiovascular and renal protective effects, making it a robust option for managing type 2 diabetes and its associated comorbidities.
Uses
- Treatment of type 2 diabetes mellitus.
- To improve glycemic control in adults.
- As an adjunct to diet and exercise.
- When both linagliptin and dapagliflozin are appropriate.
Directions For Use
Take this medication orally, once daily in the morning, with or without food, as directed by your healthcare provider. Swallow the tablet whole.
Benefits
- Provides complementary mechanisms for glucose lowering.
- Effectively reduces HbA1c levels.
- Contributes to modest weight loss.
- Offers cardiovascular and renal protective benefits.
- Low risk of hypoglycemia (as monotherapy).
- Improves insulin secretion and reduces glucose reabsorption.
Side Effects
- Genital yeast infections
- Urinary tract infections (UTIs)
- Increased urination
- Thirst
- Dizziness
- Hypotension (low blood pressure)
- Ketoacidosis (rare but serious)
- Joint pain (arthralgia)
- Nasopharyngitis
- Back pain
- Nausea
- Flu-like symptoms
Safety Measures
- Alcohol - Limit alcohol intake as it can increase the risk of ketoacidosis (due to dapagliflozin) and hypoglycemia.
- Pregnancy - Not recommended during the second and third trimesters of pregnancy due to potential adverse effects on fetal kidney development. Consult a doctor.
- Breastfeeding - Avoid use during breastfeeding as it is unknown if components are excreted in human milk and could pose risks to the infant.
- Liver - Generally safe for use in mild to moderate liver impairment; however, caution is advised, and monitoring may be necessary in severe cases.
- Kidney - Use with caution and dose adjustment may be required for dapagliflozin in patients with impaired renal function. Not recommended for severe renal impairment.
- Lung - No specific contraindications or major concerns related to lung conditions; however, general patient health should always be considered.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!